FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to group of novel individual chemical compounds, namely to cyclic amino-compounds represented by the following formula (I): where R1 means phenyl group that can be substituted optionally with at least one substituent representing halogen atom; R2 means C1-C8-aliphatic acyl group or (C1-C4-alkoxy)-carbonyl group; R3 means saturated cyclic amino-group comprising from 2 to 8 carbon atoms in one or some cycles being the greatest nitrogen-containing cycle has from 3 to 7 atoms in cycle and indicated saturated cyclic amino-group is substituted with group of the formula S-X-R4 where R4 and X have values given below and indicated saturated cyclic amino-group is linked through its cyclic nitrogen atom to adjacent carbon atom to which substituents R2 and R1 are linked also; R4 means phenyl group that can be substituted optionally with at least one substituent taken among group consisting of halogen atoms, C1-C4-alkyl groups, C1-C4-alkoxyl groups and nitro-groups; C1-C6-alkyl group that can be substituted optionally with at least one substituent taken among group consisting of amino-groups, carboxyl groups, (C1-C4- alkoxy)-carbonyl groups, substituents of the formula NH-A1 (where A1 means α-amino acid residue) and substituents of the formula CO-A2 (where A2 means α-amino acid residue); or C3-C8- cycloalkyl group; X means sulfur atom, sulfyl group or sulfonyl group and the above mentioned cyclic amino-containing group can be substituted additionally but optionally with group of the formula =CR5R6 where R5 and R6 are similar or different and each means independently hydrogen atom, carboxyl group, (C1-C4-alkoxy)-carbonyl group, carbamoyl group, (C1-C4-alkyl)-carbamoyl group or di-(C1-C4-alkyl)-carbamoyl group; or their pharmacologically acceptable salts, pharmaceutical composition eliciting inhibitory effect on platelets aggregation; medicinal preparation containing amino-compound of the formula (I) and to method of prophylaxis of diseases taken among group consisting of embolism and thrombosis in warm-blooded animal. EFFECT: valuable medicinal properties of compounds. 30 cl, 7 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLIC AMINODERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT AND PROPHYLAXIS OF DISEASES | 1997 |
|
RU2163596C2 |
CALCIUM BLOCKING AGENT-CONTAINING STABILIZED PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2239432C2 |
DERIVATIVES OF TETRAHYDROTHIENO-[3,2-C]-PYRIDINE OR THEIR FURO-ANALOGS AND A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2089553C1 |
PYRROLOPYRIDAZINE DERIVATIVES | 2001 |
|
RU2254335C2 |
METHOD FOR PRODUCING HIGH-PURITY PRASUGREL HYDROCHLORIDE | 2008 |
|
RU2435776C2 |
DERIVATIVE OF 8-TRIFLUOROMETHYLQUINOLINE CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF IMMUNODEFICIENCY VIRUS | 1995 |
|
RU2140919C1 |
ASPIRIN-COMPRISING MEDICINAL COMPOSITIONS | 2001 |
|
RU2262933C2 |
METHOD OF PREPARING DIHYDROPYRIDINE DERIVATIVES | 0 |
|
SU1831476A3 |
DERIVATIVES OF BENZAMIDINE | 2000 |
|
RU2222529C2 |
5-HYDROXYPYRIMIDINE-4-CARBOXAMIDE DERIVATIVE | 2010 |
|
RU2550693C2 |
Authors
Dates
2003-05-10—Published
1999-02-26—Filed